Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-013673)

Filing Details

Accession Number:: 0001415889-25-013673
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-19 17:42:21
Reporting Period:: 2025-05-16

Filing Date:: 2025-05-19
Accepted Time:: 2025-05-19 17:42:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1211583	Fennec Pharmaceuticals Inc.	FENC	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1926254	S. Jeffrey Hackman	68 Tw Alexander Drive Po Box 13628 Research Triangle Park NC 27709	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2025-05-16	1,035	$6.75	1,035	No	4	P	Direct
Common Shares	Acquisiton	2025-05-19	13,965	$6.99	15,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Transaction Code P - Open market or private purchase of non-derivative or derivative security